| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 4.489 | 6.409 | 2.830 | 7.969 | 19.531 | 57.294 |
| Total Income - EUR | - | - | - | - | 5.741 | 13.787 | 8.068 | 12.941 | 23.480 | 71.331 |
| Total Expenses - EUR | - | - | - | - | 1.257 | 13.454 | 9.590 | 8.570 | 8.627 | 43.344 |
| Gross Profit/Loss - EUR | - | - | - | - | 4.484 | 332 | -1.521 | 4.371 | 14.854 | 27.987 |
| Net Profit/Loss - EUR | - | - | - | - | 4.439 | 268 | -1.608 | 4.132 | 12.477 | 23.128 |
| Employees | - | - | - | - | 2 | 2 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Capital Infuse Advisor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 7.267 | 25.031 | 17.771 | 11.389 | 7.524 | 43.748 |
| Current Assets | - | - | - | - | 20.310 | 3.084 | 1.862 | 7.575 | 22.219 | 68.160 |
| Inventories | - | - | - | - | 0 | 1.028 | 1.005 | 1.008 | 1.107 | 1.101 |
| Receivables | - | - | - | - | 0 | 103 | 0 | 5.069 | 2.502 | 50.124 |
| Cash | - | - | - | - | 20.310 | 1.953 | 858 | 1.498 | 18.610 | 16.934 |
| Shareholders Funds | - | - | - | - | 4.481 | 4.665 | 2.953 | 7.093 | 19.549 | 42.568 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 742 | 1.180 | 142 | 253 | 2.160 | 65.152 |
| Income in Advance | - | - | - | - | 22.353 | 22.271 | 16.539 | 11.618 | 8.034 | 4.188 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Capital Infuse Advisor S.r.l.